Onion extract may lower blood sugar, cholesterol in diabetes
the ONA take:
Allium cepa, an extract found in onion bulbs, may be able to lower high blood glucose as well as total cholesterol levels in diabetes, according to a study presented at The Endocrine Society meeting in San Diego.
Investigators led by Anthony Ojieh, MD, of Delta State University in Nigeria conducted a study on rats with medically-induced diabetes, administering metformin and onion extract doses by varying doses based on body weight to three groups of rats.
They also administered the same type of treatment to three groups of rats without diabetes and normal blood sugar levels. Two final groups with and without diabetes received only metformin with no onion extract.
They found that two doses of the onion extract, at 400 and 600 mg/kg/day, greatly reduced fasting blood sugar levels in diabetic rats by 50 and 35 percent, respectively, compared with when they were not receiving the extract. Additionally, the diabetic rats undergoing these two dosages were found to have lower total cholesterol levels.
A histologic study of the pancreas that was removed from each of the diabetic rats showed that neither the metformin nor the onion extract had healed damage from the drug-induced diabetes.
“We need to investigate the mechanism by which onion brought about the blood glucose reduction,” Dr. Ojieh said. “We do not yet have an explanation.”
Allium cepa, an extract found in onion bulbs, may be able to lower high blood glucose as well as total cholesterol levels in diabetes.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|